Top Story

Doublet therapy safe, effective in heavily pretreated non-Hodgkin's lymphoma

August 3, 2015

Combination therapy with temsirolimus and bortezomib demonstrated safety and efficacy in patients with heavily pretreated B-cell non-Hodgkin’s lymphoma, according to the results of a phase 2 study.

“For many types of non-Hodgkin’s lymphoma, there remains a significant unmet need for additional treatment options, especially in the relapsed and refractory setting,” Timothy S. Fenske, MD, associate professor of medicine at Medical College of Wisconsin, told HemOnc Today. “Individually, each of these drugs has shown activity in different types of lymphoma, and preclinical data suggests that treatment with two classes of drugs may have additive or synergistic effects.”

Stephen L. Lessnick, MD, PhD Institution Notes

Center for Childhood Cancer and Blood Disorders appoints director

August 2, 2015
Stephen L. Lessnick, MD, PhD, has been named director of the Center for Childhood Cancer and Blood Disorders at Nationwide Children’s Hospital in Columbus…
Josep Tabernero, MD, PhD Association News

ESMO announces 2018 2019 president

August 1, 2015
Josep Tabernero, MD, PhD, will serve as president of the European Society for Medical Oncology in 2018-2019.Tabernero is head of the medical oncology department at Vall…

Persistent HPV16 DNA in oral rinses predicts oropharyngeal cancer recurrence

July 31, 2015
The presence of HPV type 16 DNA in oral rinses following treatment for HPV-related oropharyngeal cancer corresponded with poor prognosis and may serve as a potential…
Raghu Kalluri, MD, PhD In the Journals

Blood particles may help detect early-stage pancreatic cancer

July 31, 2015
Glypicin-1 circulating exosomes may serve as a biomarker for the non-invasive detection for early-stage pancreatic cancer, according to study results.The detection of…
More News Headlines »
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
VIDEO: 'Care paths' may help manage rising cancer costs

VIDEO: 'Care paths' may help manage rising cancer costs

June 19, 2015
CHICAGO — Brian Bolwell, MD, chairman of Taussig Cancer Institute at Cleveland Clinic, discusses an abstract on…
More »
Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for…
More »